PFOS induces proliferation, cell-cycle progression, and malignant phenotype in human breast epithelial cells
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Perfluorooctanesulfonic acid (PFOS) is a synthetic fluorosurfactant widely used in the industry and a prominent environmental toxicant. PFOS is persistent, bioaccumulative, and toxic to mammalian species. Growing evidence suggests that PFOS has the potential to interfere with estrogen homeostasis, posing a risk of endocrine-disrupting effects. Recently, concerns about a potential link between PFOS and breast cancer have been raised, but the mechanisms underlying its actions as a potential carcinogen are unknown. By utilizing cell proliferation assays, flow cytometry, immunocytochemistry, and cell migration/invasion assays, we examined the potentially tumorigenic activity of PFOS (100 nM–1 mM) in MCF-10A breast cell line. The results showed that the growth of MCF-10A cells exposed to 1 and 10 µM PFOS was higher compared to that of the control. Mechanistic studies using 10 µM PFOS demonstrated that the compound promotes MCF-10A proliferation through accelerating G 0 /G 1- to-S phase transition of the cell cycle after 24, 48, and 72 h of treatment. In addition, PFOS exposure increased CDK4 and decreased p27, p21, and p53 levels in the cells. Importantly, treatment with 10 µM PFOS for 72 h also stimulated MCF-10A cell migration and invasion, illustrating its capability to induce neoplastic transformation of human breast epithelial cells. Our experimental results suggest that exposure to low levels of PFOS might be a potential risk factor in human breast cancer initiation and development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · cited 1×
“Low levels or loss of p27 and p21 expression is a significant predictor of reduced survival, tumor progression, and prognosis (Abbas and Dutta 2009; Catzavelos et al.”
Olsen, G. W., Burris, J. M., Ehresman, D. J., Froehlich, J. W., Seacat, A. M., Butenhoff, J. L., & Zobel, L. R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.10009 · Cited by 2,049
Polyfluorinated Compounds: Past, Present, and Future
Lindstrom, A. B., Strynar, M. J., & Libelo, E. L. (2011) · Environmental Science & Technology · doi:10.1021/es2011622 · Cited by 1,628 · cited 1×
“Perfluorooctanesulfonic acid (PFOS), is a man-made fluorosurfactant that has been used as lubricant, component of polishes, paints, paper, textile coatings, food packaging, and fire-retardant foams (Lindstrom et al. 2011).”
Treating cancer with selective CDK4/6 inhibitors
O'Leary, B., Finn, R. S., & Turner, N. C. (2016) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.26 · Cited by 1,137
Johansson, N., Fredriksson, A., & Eriksson, P. (2008) · NeuroToxicology · doi:10.1016/j.neuro.2007.10.008 · Cited by 463 · cited 1×
“There is growing evidence that PFOS may disrupt the endocrine system (Johansson et al. 2008; Wang et al. 2011).”
Environmental pollutants and breast cancer: Epidemiologic studies
Brody, J. G., Moysich, K. B., Humblet, O., Attfield, K. R., Beehler, G. P., & Rudel, R. A. (2007) · Cancer · doi:10.1002/cncr.22655 · Cited by 375 · cited 2×
“Among them, both estrogens and non-estrogenic endocrine disruptors are considered to play critical roles in human breast carcinogenesis (Brody et al. 2007).”
Boulanger, B., Vargo, J. D., Schnoor, J. L., & Hornbuckle, K. C. (2005) · Environmental Science & Technology · doi:10.1021/es050213u · Cited by 283 · cited 1×
“PFOS and PFOS-containing products are released to the environment, contaminating soil, sediment, sludge, and water (Boulanger et al. 2005; Skutlarek et al. 2006).”
Biodegradation of Perfluorinated Compounds
Parsons, J. R., Sáez, M., Dolfing, J., & de Voogt, P. (2008) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/978-0-387-78444-1_2 · Cited by 258
Molecular pathways: CDK4 inhibitors for cancer therapy
Dickson, M. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1551 · Cited by 245
McAllister, S. D., Murase, R., Christian, R. T., Lau, D., Zielinski, A. J., Allison, J., Almanza, C., Pakdel, A., Lee, J., Limbad, C., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1177-4 · Cited by 229 · cited 1×
“Invasion and metastasis of aggressive breast cancer cells are the final and fatal step during cancer progression (McAllister et al. 2011).”
Cited by
Risk to human health related to the presence of perfluoroalkyl substances in food
Panel), E. P. O. C. I. T. F. C. (. C., Schrenk, D., Bignami, M., Bodin, L., Chipman, J. K., del Mazo, J., Grasl‐Kraupp, B., Hogstrand, C., Hoogenboom, L. (., Leblanc, J., et al. (2020) · EFSA Journal · doi:10.2903/j.efsa.2020.6223 · Cited by 989
Rickard, B. P., Rizvi, I., & Fenton, S. E. (2022) · Toxicology · doi:10.1016/j.tox.2021.153031 · Cited by 334
Pierozan, P., Cattani, D., & Karlsson, O. (2022) · Science of The Total Environment · doi:10.1016/j.scitotenv.2021.151945 · Cited by 68
Self-citationInvolvement of per-and polyfluoroalkyl compounds in tumor development
Pesonen, M., & Vähäkangas, K. (2024) · Archives of Toxicology · doi:10.1007/s00204-024-03685-7 · Cited by 40
Metadata
- Authors
- Pierozan, P., & Karlsson, O.
- Venue
- Archives of Toxicology
- Published
- 2017-10-23
- Volume
- 92
- Issue
- 2
- Pages
- 705-716
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2766254384
- Cited by
- 85
- References
- 12
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: PFOS induces proliferation, cell-cycle progression, and malignant phenotype in human breast epithelial cells. https://app.cochat.ai/papers/10.1007/s00204-017-2077-8
- The paper
- Pierozan, P., & Karlsson, O. (2018). PFOS induces proliferation, cell-cycle progression, and malignant phenotype in human breast epithelial cells. Archives of Toxicology. https://doi.org/10.1007/s00204-017-2077-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.